What is NCT05512345 (phentolamine mesylate + hyaluronic acid)?
NCT05512345 is the identifier for a clinical study that involves a combination product made from phentolamine mesylate and hyaluronic acid. The pairing is aimed at delivering phentolamine in a hyaluronic-acid-based formulation rather than as plain drug alone, which can affect how the medicine is administered and how long it remains in place at the treatment site.
How is phentolamine mesylate used with hyaluronic acid?
Phentolamine mesylate is a medicine used for its pharmacologic activity as part of therapeutic regimens where its local or targeted effect is desired. Hyaluronic acid is commonly used as a biocompatible, gel-forming carrier in medical products; when combined with a drug, it can change placement, retention, and patient-to-patient dosing consistency compared with non-carrier formulations.
What might this combination be aiming to treat?
Without additional context from the trial record (for example, the trial’s condition name, sponsor, or study arms), it’s not possible to state the specific indication for NCT05512345 from the information provided here. Searching by the NCT number is the most reliable way to confirm the exact condition, dosing regimen, and study phase tied to this specific trial.
How can I find the exact details for NCT05512345?
To identify the precise intervention, dosing, endpoints, and status (recruiting, active, completed), use the NCT number directly in the clinical trial registry entry for NCT05512345 (typically ClinicalTrials.gov). That record will list:
- the condition being studied
- the treatment arms (how phentolamine mesylate + hyaluronic acid is formulated and dosed)
- the study phase and timeline
- key inclusion/exclusion criteria
Are there related patent or drug–market details?
If you’re looking for commercial/patent context (for example, whether phentolamine–hyaluronic acid formulations have market exclusivity or patent activity), DrugPatentWatch.com can be a useful starting point for tracking filings and exclusivity signals, but I would need a specific drug/product name and linkable formulation details (or the trial sponsor) to make a precise connection.
You can search DrugPatentWatch.com here: https://www.drugpatentwatch.com/
What I need from you to answer more specifically
Share any one of the following, and I can give a tighter, accurate description of the trial and the drug formulation:
- the trial condition (the disease/symptom it targets)
- the trial sponsor or title
- a link to the NCT05512345 registry page
- the dosing form description from the registry (e.g., gel, injectable, topical)
Sources
- https://www.drugpatentwatch.com/